Northfield Laboratories
Knobias ClipReport (9-4-2007)
Tuesday, September 4th, 2007Rating 3.00 out of 5
[?]Submitted from Knobias ClipReport
Cash rich biopharmaceuticals seem to be on the trading radar of many in the small arena again. These lowered risk, waiting game type companies have cash equal to market cap, drugs in the pipeline, and possibilities, albeit sometimes small, to develop revenue producing drugs.
Northfield Laboratories Inc. (NFLD) […]
